Premier Hemp Labs and Leading CBD Retailer Call for Industry Reform and Standardized Testing
LAS VEGAS — As cannabinoids become more mainstream and the hemp and cannabis industries evolve, it should be commonplace for consumers to find high-quality options based on their product labels. Consumers relying on the information in a product COA (Certificate of Analysis) is standard when it comes to shopping for CBD and other cannabinoids. However, a lack of transparency from both CBD brands and some third-party laboratories threatens that goal. Discrepancies, sometimes exceeding 30-50% in cannabinoid content, between results reported on brand COAs and independent laboratory tests are becoming more common. Particularly when it comes to cannabinoids derived from conversions like delta-8 THC. Third-party laboratories are reporting different (usually lower) concentrations of cannabinoids compared to label claims. For consumers looking to avoid traditional THC (delta-9) or other substances, this can be a serious concern; severe enough that consequences could extend from health issues,...